In a large-sample randomized-controlled trial in T1DM conducted by Panduru et al., KIM-1 had no predictive value for progression to ESKD independently of albumin excretion rate (AER) and added no prognostic benefit to conventional biomarkers (AER, eGFR). Here, ALB is linked to type 1 diabetes mellitus.